Resource

 

 

 

 

 

 

 

 

 

 

 

Banking & Finance - Capital Markets: Equity

Heuking Kühn Lüer Wojtek advises GxP German Properties on combined cash and capital increase

28 Nov 2016

With a team led by Dr. Thorsten Kuthe, Partner at the firm's Cologne office, Heuking Kühn Lüer Wojtek advised GxP German Properties AG on a combined cash and capital increase. As a result of the new share issue, the shares in German Investment Management Holding GmbH, which is currently operating on the market with its subsidiary GxP Asset Management GmbH, were contributed in kind. At the same time, a cash capital increase with issue proceeds of EUR 27 million was carried out.
 

Shearman & Sterling Advises Underwriters on VPower’s Hong Kong IPO

28 Nov 2016

Shearman & Sterling advised BOCI Asia Limited, Citigroup Global Markets Asia Limited, CMB International Capital Limited, Haitong International Securities Company Limited and The Hongkong and Shanghai Banking Corporation Limited as underwriters on the US$208 million global offering and initial public offering of VPower Group International Holdings Limited (VPower) on the Main Board of The Stock Exchange of Hong Kong Limited.

Baker & McKenzie acts for underwriter of initial public offering for Dreamscape Networks Limited

28 Nov 2016

Baker & McKenzie is acting for Canaccord Genuity (Australia) Limited, the underwriter and  Lead Manager for the initial public offering (IPO) and ASX listing of Dreamscape Networks Limited.

The IPO seeks to raise $25 million, and the company is scheduled to list on the ASX in early December 2016. The institutional component of the offer was also extended to investors in Hong Kong, New Zealand and Singapore.

Dreamscape is is the leading domain name brand in Australia with 30 per cent market share according to press reports.

Eversheds advises Stifel as sponsor on the transfer of Secure Trust Bank plc from AIM to the Official List

28 Nov 2016

Eversheds has advised brokerage and investment firm Stifel Nicolaus Europe in its role as sponsor to Secure Trust Bank plc on the admission of its shares to the Official List of the UK Listing Authority from AIM.

The admission of Secure Trust Bank’s shares to the Official List and to trading on the Main Market took effect on 12 October at 8.00am.

The Eversheds team was led by corporate partner Sebastian Orton and principal associate Jon Stanley.

Sebastian Orton commented:

Travers Smith advises Shore Capital, Panmure Gordon and Stifel Nicolaus Europe on Chesnara’s firm placing and placing and open offer

28 Nov 2016

Travers Smith LLP has advised Shore Capital and Panmure Gordon in their capacities as sponsor and joint bookrunners and Stifel Nicolaus Europe (trading as Keefe, Bruyette & Woods) in its capacity as placing agent in connection with the £70 million firm placing and placing and open offer of new shares by Chesnara plc in connection with its acquisition of Legal & General Nederland Levensverzekering Maatschappij N.V. for €160 million.

Stephenson Harwood advises on £350 million social housing IPO

28 Nov 2016

Stephenson Harwood LLP has advised Cenkos Securities plc and Zeus Capital in connection with the launch of Civitas Social Housing PLC, the first Real Estate Investment Trust targeted at the social housing market.

Civitas Social Housing PLC will be listed on the Official List of the UK Listing Authority and trade on the main market of the London Stock Exchange. Cenkos Securities plc is the sole sponsor and financial adviser, and Cenkos Securities and Zeus Capital are the joint placing agents.

Sidley Advises on the Initial Public Offering of JNBY Design Limited

28 Nov 2016

Sidley has advised CCB International Capital Limited as the sole sponsor and the sole global coordinator, which together with CITIC CLSA Securities  as the underwriters, in connection with the initial public offering of JNBY Design Limited (JNBY) on the Stock Exchange of Hong Kong. JNBY is a leading designer brand fashion house based in China. The total offering amount was approximately HK$800 million (US$103 million).

Setterwalls assists Alligator Bioscience AB in connection with listing on Nasdaq Stockholm

25 Nov 2016

Alligator Bioscience AB is a research company based in Lund, that is developing antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies and operates in the early phases of drug development, from the idea stage to clinical phase II trials. In August 2015, the company’s furthest developed product candidate, ADC-1013, was licensed to Janssen Biotech, Inc., a company in the Johnson & Johnson group, for further development and commercialization.